[Should benefit-risk ratio of the intramuscular vitamin K be reevaluated in newborn infants?].
Autret
E
E
Service de pharmacologie clinique, hôpital Bretonneau, Tours, France.
Jonville-Bera
A P
AP
D000367:Age Factors; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D009369:Neoplasms / Q000139:chemically induced; D016017:Odds Ratio; D018570:Risk Assessment; D014812:Vitamin K / Q000008:administration & dosage* / Q000009:adverse effects; D006475:Vitamin K Deficiency Bleeding / Q000139:chemically induced
D014812:Vitamin K
Le rapport bénéfice/risque de la vitamine K intramusculaire doit-il être réévalué chez le nouveau-né?